profit from every R$100 of sales.
R$0R$100
Empreendimentos Pague Menos
R$2.39-0.83% today
-36.4% in 1 year
1-year low R$2.381-year high R$7.54
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay R$6.58 for every R$1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Empreendimentos Pague Menos sold, what it kept, and what it did with the cash.
Sales went from R$9.19 billion in 2022 to R$14.9 billion in 2025, with R$260 million of profit last year.
SalesProfit
Empreendimentos Pague Menos vs. similar companies
Empreendimentos Pague Menos grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from R$100 of sales | Sales growth a year | Price per R$1 of profit |
|---|---|---|---|
| Empreendimentos Pague Menos | 6.6× · Cheap | ||
 JD Health International | 20.5× · Fair price | ||
 Tsuruha Holdings | 26.6× · Fair price | ||
 MatsukiyoCocokara & | 19.7× · Fair price | ||
 Yifeng Pharmacy Chain | 18.4× · Fair price |
AI analysis
An AI analyst reads Empreendimentos Pague Menos's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 9,189 | 11,202 | 12,642 | 14,906 | |
| 2,951 | 3,545 | 4,026 | 4,763 | |
| 632 | 407 | 568 | 854 | |
| 1,108 | 798 | 958 | 1,206 | |
| 264 | 3 | 103 | 260 | |
| 0.58 | 0.00 | 0.22 | 0.40 | |
| 32.1% | 31.6% | 31.8% | 32.0% | |
| 6.9% | 3.6% | 4.5% | 5.7% | |
| 2.9% | 0.0% | 0.8% | 1.7% |
Balance sheet
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 8,597 | 8,989 | 9,022 | 9,921 |
| Cash | 164 | 439 | 149 | 186 |
| Total debt | 3,813 | 3,757 | 3,507 | 3,690 |
| Total liabilities | 6,254 | 6,328 | 6,299 | 6,828 |
| 2,335 | 2,653 | 2,715 | 3,085 | |
| 453 | 510 | 582 | 665 | |
| 7.7% | 2.8% | 4.7% | 6.6% | |
| 11.3% | 0.1% | 3.8% | 8.4% |
Cash flow
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 146 | 492 | 384 | 200 | |
| 326 | 123 | 102 | 261 | |
| -179 | 368 | 282 | -61 | |
| Dividends paid | – | 82 | 43 | 176 |
| 20 | 9 | 23 | 16 | |
| – | – | – | – |
Valuation
- 6.6×
- –
- –
- 0.9×
- 0.1×
- –
- 4.3×
- -3.6%
- 15.2%
- 10.3%
Profitability
- 32.0%
- 5.7%
- 1.7%
- –
- 6.6%
- 5.4%
- –
- –
- –
- –
Growth
- +17.5%
- −11.7%
- –
- –
- +13.7%
Financial health
- 2.9×
- 1.20
- –
- 1.3×
- 1.59
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 44%of 952
Bottom 39%of 884
Top 4%of 601
Top 31%of 886
Bottom 22%of 987
10.3%of the share price, paid each year
On $1,000 invested$103a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
67.8% of its profit
Room to growStretchedMore than it earnsNews
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
82Pass
Philip Fisher
29No pass
Peter Lynch
30No pass
Joel Greenblatt
57No pass
Charlie Munger
16No pass
Terry Smith
17No pass
Questions about Empreendimentos Pague Menos
Is Empreendimentos Pague Menos a good stock to buy?
A business with weak numbers, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Empreendimentos Pague Menos AI analysis
What does Empreendimentos Pague Menos do?
Empreendimentos Pague Menos S.A. engages in the retail sale of medicines, perfumeries, and personal hygiene and beauty products in Brazil. It is in Pharmaceutical Retailers, based in Fortaleza, CE, Brazil, with 26,261 employees.
Does Empreendimentos Pague Menos pay a dividend?
Yes. At today's price the dividend is 10.3% a year, about 68% of its yearly profit. In 2025 it paid out R$176 million in dividends.
Is Empreendimentos Pague Menos stock halal?
No. Empreendimentos Pague Menos does not pass our halal screen: its debt is 215% of its market value, at or above the 33% limit. How we check
How has Empreendimentos Pague Menos stock done over the past year?
Down 36.4% over the past twelve months, to R$2.39. It traded between R$2.38 and R$7.54 and is 68.3% below its high.
Who are Empreendimentos Pague Menos's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with Empreendimentos Pague Menos's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.